Novartis is an innovative medicines company dedicated to improving and extending people's lives by reimagining medicine. With a focus on cardiovascular, immunology, neuroscience, solid tumors, hematology, chemistry, xRNA, radioligand, and gene and cell therapy, Novartis reaches over 250 million patients worldwide. The company was founded in 1996 by Daniel Vasella and is headquartered in Basel, Switzerland. Novartis is publicly traded and employs over 10,000 people globally.

Novartis is at the forefront of medical innovation, developing cutting-edge therapies for a range of diseases. The company is committed to addressing unmet medical needs and improving patient outcomes.